A call to action for the treatment of acute promyelocytic leukemia in the modern era: It is no longer just about the ATRA and arsenic

被引：0
作者：
Pemmaraju, Naveen [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd, Houston, TX 77030 USA
来源：
CANCER | 2021年 / 127卷 / 16期
关键词：
access to care; APL; insurance status; Medicaid; Mortality; ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; YOUNG-ADULTS; PATIENT CHARACTERISTICS; RETINOIC ACID; UNITED-STATES; OUTCOMES; ADOLESCENTS; TRIOXIDE;
D O I：
10.1002/cncr.33594
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Overall, outcomes for most patients with acute promyelocytic leukemia have dramatically improved over the past 2 decades; however, in the United States, in one particular subset, it has been observed that patients without medical insurance have experienced far worse outcomes than their counterparts with insurance. This editorial serves as a call to action in our field to begin to understand and discuss improving inequities in our health care system for patients with highly curable but rare hematologic malignancies.
引用
收藏
页码：2867 / 2869
页数：3
相关论文
共 24 条
  • [1] Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab
    Abaza, Yasmin
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Estey, Elihu
    Borthakur, Gautam
    Jabbour, Elias
    Faderl, Stefan
    O'Brien, Susan
    Wierda, William
    Pierce, Sherry
    Brandt, Mark
    Mccue, Deborah
    Luthra, Rajyalakshmi
    Patel, Keyur
    Kornblau, Steven
    Kadia, Tapan
    Daver, Naval
    DiNardo, Courtney
    Jain, Nitin
    Verstovsek, Srdan
    Ferrajoli, Alessandra
    Andreeff, Michael
    Konopleva, Marina
    Estrov, Zeev
    Foudray, Maria
    Mccue, David
    Cortes, Jorge
    Ravandi, Farhad
    [J]. BLOOD, 2017, 129 (10) : 1275 - 1283
  • [2] The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
    Abboud, Camille
    Berman, Ellin
    Cohen, Adam
    Cortes, Jorge
    DeAngelo, Daniel
    Deininger, Michael
    Devine, Steven
    Druker, Brian
    Fathi, Amir
    Jabbour, Elias
    Jagasia, Madan
    Kantarjian, Hagop
    Khoury, Jean
    Laneuville, Pierre
    Larson, Richard
    Lipton, Jeffrey
    Moore, Joseph O.
    Mughal, Tariq
    O'Brien, Susan
    Pinilla-Ibarz, Javier
    Quintas-Cardama, Alfonso
    Radich, Jerald
    Reddy, Vishnu
    Schiffer, Charles
    Shah, Neil
    Shami, Paul
    Silver, Richard T.
    Snyder, David
    Stone, Richard
    Talpaz, Moshe
    Tefferi, Ayalew
    Van Etten, Richard A.
    Wetzler, Meir
    Abruzzese, Elisabetta
    Apperley, Jane
    Breccia, Massimo
    Byrne, Jenny
    Cervantes, Francisco
    Chelysheva, Ekaterina
    Clark, R. E.
    de Lavallade, Hugues
    Dyagil, Iryna
    Gambacorti-Passerini, Carlo
    Goldman, John
    Haznedaroglu, Ibrahim
    Hjorth-Hansen, Henrik
    Holyoake, Tessa
    Huntly, Brian
    le Coutre, Philipp
    Lomaia, Elza
    [J]. BLOOD, 2013, 121 (22) : 4439 - 4442
  • [3] Acute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript: an aggressive APL variant
    Alotaibi, Ahmad S.
    Abdulrazzaq, Mustafa
    Patel, Keyur P.
    Ravandi, Farhad
    Konoplev, Sergej
    Bueso-Ramos, Carlos
    Yin, C. Cameron
    Muzzafar, Tariq
    Tang, Guilin
    Futreal, Andrew
    Jain, Nitin
    Konopleva, Marina Y.
    Pemmaraju, Naveen
    [J]. LEUKEMIA & LYMPHOMA, 2020, 61 (12) : 3018 - 3020
  • [4] Differences in Outcomes of Newly Diagnosed Acute Myeloid Leukemia for Adolescent/Young Adult and Younger Patients A Report from the Children's Oncology Group
    Canner, Jason
    Alonzo, Todd A.
    Franklin, Janet
    Freyer, David R.
    Gamis, Alan
    Gerbing, Robert B.
    Lange, Beverly J.
    Meshinchi, Soheil
    Woods, William G.
    Perentesis, John
    Horan, John
    [J]. CANCER, 2013, 119 (23) : 4162 - 4169
  • [5] Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia
    Chamoun, Kamal
    Kantarjian, Hagop
    Wang, Xuemei
    Naqvi, Kiran
    Aung, Fleur
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Jabbour, Elias
    Kadia, Tapan
    Daver, Naval
    DiNardo, Courtney D.
    Jain, Nitin
    Konopleva, Marina
    Cortes, Jorge
    Ravandi, Farhad
    Yilmaz, Musa
    [J]. CANCER, 2019, 125 (18) : 3219 - 3224
  • [6] Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis
    Daver, Naval
    Kantarjian, Hagop
    Marcucci, Guido
    Pierce, Sherry
    Brandt, Mark
    Dinardo, Courtney
    Pemmaraju, Naveen
    Garcia-Manero, Guillermo
    O'Brien, Susan
    Ferrajoli, Alessandra
    Verstovsek, Srdan
    Popat, Uday
    Hosing, Chitra
    Anderlini, Paolo
    Borthakur, Gautam
    Kadia, Tapan
    Cortes, Jorge
    Ravandi, Farhad
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (05) : 646 - 653
  • [7] Outcome of Therapy-Related Acute Promyelocytic Leukemia With or Without Arsenic Trioxide as a Component of Frontline Therapy
    Dayyani, Farshid
    Kantarjian, Hagop
    O'Brien, Susan
    Pierce, Sherry
    Jones, Dan
    Fader, Stefan
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Ravandi, Farhad
    [J]. CANCER, 2011, 117 (01) : 110 - 115
  • [8] How I treat acute myeloid leukemia in the era of new drugs
    DiNardo, Courtney D.
    Wei, Andrew H.
    [J]. BLOOD, 2020, 135 (02) : 85 - 96
  • [9] Jamy OH, 2021, CANCER, V127
  • [10] Health care in the United States-basic human right or entitlement?
    Jones, G. H.
    Kantarjian, H.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (10) : 2193 - 2195
123